Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients
- 27 January 2017
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 69 (12) , 1909-1914
Abstract
Objective: To characterize the cutaneous and systemic clinical phenotype of dermatomyositis patients with antinuclear matrix protein 2 (anti–NXP‐2) antibodies.Methods: We conducted a retrospective cohort analysis of 178 dermatomyositis patients seen at the Stanford University Clinic. An electronic chart review employing a keyword search strategy was performed to collect clinical and laboratory data. Anti–NXP‐2 antibodies were assayed by immunoprecipitation using NXP‐2 produced by in vitro transcription/translation.Results: Antibodies to NXP‐2 were detected in 20 of the 178 patients (11%). Anti–NXP‐2 antibodies were associated with male sex (50% versus 25%; P = 0.02), dysphagia (74% versus 39%; P = 0.006), myalgia (89% versus 52%; P = 0.002), peripheral edema (35% versus 11%; P = 0.016), and calcinosis (37% versus 11%; P = 0.007). These patients were less likely to be clinically amyopathic (5% versus 23%; P = 0.08). Five of the 20 patients with anti–NXP‐2 antibodies (25%) had an associated internal malignancy. No other cutaneous characteristics were associated with anti–NXP‐2 antibodies, except a decreased frequency of Gottron's sign (44% versus 75%; P = 0.012) and a greater likelihood of having mild skin disease.Conclusion: Dermatomyositis patients with anti–NXP‐2 antibodies have a distinct and often severe systemic phenotype that includes myalgia, peripheral edema, and significant dysphagia, despite having milder inflammatory skin disease.Keywords
Funding Information
- National Institutes of Health (P30-AR-053503, R01-AR-44684, AR-062615-01A1)
This publication has 26 references indexed in Scilit:
- Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γArthritis & Rheumatism, 2013
- The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory MyopathiesMedicine, 2013
- Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancyAnnals of the Rheumatic Diseases, 2012
- Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositisArthritis Research & Therapy, 2012
- Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2Rheumatology, 2012
- Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa ProteinThe Journal of Rheumatology, 2009
- Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosisArthritis & Rheumatism, 2009
- Anasarca: not a nephrotic syndrome but dermatomyositisEuropean Journal of Pediatrics, 2008
- Dynamic Regulation of p53 Subnuclear Localization and Senescence by MORC3Molecular Biology of the Cell, 2007
- Childhood polymyositis as a paraneoplastic phenomenonPediatric Neurology, 1993